chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient was with her father and older brother. Both children were to receive TDAP, HPV, and MCV4.  I verified allergies (NKA,) child's weight, and if the child had eaten anything today (father reported both children had eaten breakfast.) I gave the MCV4 in the right arm first, TDAP 2nd in the upper left deltoid, and HPV last about one inch below the TDAP; this was around 1530. The patient was sitting on an exam table/ bench with her father sitting next to her. After I was retracting the HPV needle from her arm, the patient slumped over toward her father and closed her eyes. We worked quickly to move her to a laying position with her legs elevated. I checked her heart rate and BP (both in range for her age) and had an extra staff member who was already present in the room go to retrieve a snack and juice. The patient was moved to a sitting position; her face was pale but her complexion began to return to normal after she ate and drank her juice. The father was informed that this could occur with receiving vaccinations and that the patient should always eat right before coming for vaccines. The patient was walking around w/o dizziness or other symptoms within 15 mins of symptom onset and she was monitored for at least 30 minutes after.
pt recvd vax in the morning; devel high t39.5 & an apparent seizure; seen in ER by MD;
Immediately upon injection, patient said he felt "funny", so I had him lay back in his chair and breathe and asked his 22 year old brother to watch him in case he fainted while I went into the other room to get a juice or soda. I returned less than 1 minute later to find the patient unconscious and in a seizure-like state of rigidity (all muscles tensed and locked). He remained this way for approximately 1 to 2 minutes, then snapped out of it abruptly. He remained pale, light-headed, and nauseated for the next 15-20 minutes, gradually improving as he was able to drink some juice and eat a hard candy to increase his blood sugar (patient reported he had not eaten much today). After monitoring for an additional 5 to 10 minutes, his mother and brothers helped him to the car to go home and rest. The mother said although it has never happened to the patient, it has happened to other family (father, uncle, etc.), so I instructed her to continue monitoring and to seek emergency care if the episode is repeated or if his condition worsens in any way.
Patient states that he experienced lip swelling at 0700 on 2/20/22. He did not take anything for this. He states that the swelling went away by 1300 that same day.
Loss of short term memory, confusion, hypesthesia, unable to urinate, high blood pressure and pulse, loss of appetite, pain in chest was unable to function at school, clinicals, and work from 02/14/2017-02/20/17.
Pain and reduced mobility began immediately after vaccination and have continued for almost 7 months. Pain/discomfort is constant and interferes with sleep. Range of motion for shoulder joint is limited thus limiting common daily activities. After 5 months partial relief came with deep massage techniques, but only partial relief.
shooting nerve pain; Radiating pain; soreness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th May 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 mg/ml. On 27th May 2022, immediately after receiving Shingrix, the patient experienced injection site pain. On 28th May 2022, the patient experienced nerve pain and radiating pain. On an unknown date, the outcome of the injection site pain, nerve pain and radiating pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, nerve pain and radiating pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 11 July 2022 Reporter's Comments: Reporter stated patient got Shingrix vaccine. Soon after she got the shot, patient had soreness at the injection site. This soreness had resolved. Patient also reported that the next night, patient started with shooting nerve pain that went from her left shoulder to her left hand. She states that it only happens at night and is ongoing. On 28th May 2022 1 day after receiving Shingrix, the patient experienced nerve pain and Radiating pain. Reporter did not consent to follow up.
Headache, muscle pain (throughout entire body), joint pain (throughout entire body), chills and chest pain.
Side effects were late onset. Had chills, fever for 7 days and severe vertigo and dizziness. Also had lip blistering, purple lips, dryness. Had vision problems where everything felt blurry and there were black spots in line of sight. Also had numbness in face, arms and legs/feet and tingling sensation.
Awoke to hot to touch, red and swollen arm at site of injection . Rash on face spreading to jaw and neck. To MD Given Zyrtec. Itching stopped. Rash and inflammation of injection site steadily resolved gone in 2 days.
Child received vaccine on 01/30/2003. Parent called 01/31, area reported .25 reddened area size. Advised cool compress and Tylenol for discomfort. Call 02/03 from parent states area became size of fist on right thigh, slight temp on 01/30. was not talking just felt worser than normal. Taken to urgent care on Sun 02/02. Cephaleprin ordered. Parent states area is swollen 02/03, no eevated temp. Plan to provide DT next 4-5 year shots. Child diagnosed with Fifth disease on Sun 02/03/03 per parent. Had DTP x 3 not DTaP
Customer said she had nauseau vomiting and diarrhea and then when she went to bed at night she noticed a rash all over her chest and back
Patient received 2nd COVID-19 vaccine at 2:11pm.  He arrived in observation at 2:25pm.  By 2:20 pm, patient was feeling like his throat was tightening and there was a "scratchy" feeling.  Patient requested Benadryl because he knew that anaphylaxis was beginning.  Benadryl 50 mg IM given in right deltoid muscle immediately.  Charge nurse present as well for assistance.  At 2:24pm - Pulse ox 97%, Pulse 74 and BP 140/80.  Patient remained alert and orientated X3 and denied respiratory distress.  Bottle of H20 given per request.  2:40pm - Patient feeling better, remained alert and orientated but feeling tired.  Patient states no longer having tightness in throat.  BP130/80, HR 70 and PO - 97%. 2:48pm - Patient sleepy but feeling good. 2:54pm - Patient feeling good and ready to go home.  Patient lives close by and felt good to drive.  Wife at home waiting for him.  BP 128/76, HR-70 and PO 97%.  Patient denies respiratory distress or any other sign or symptom of anaphylaxis.
Pt experienced vasovagal syncope 5 minutes after receiving the Janssen Covid 19 vaccine. Pt became cool, pale, and clammy, and lost consciousness briefly. During this time, pt was breathing (moving adequate tidal volume) and maintained a radial pulse.  Pt regained consciousness about 1 minute later, and vital signs were obtained. Pt had a heart rate of 56, breathing at 16 times a minute, moving adequate tidal volume with clear lung sounds. Pt was satting at 96% on room air, and when asked questions appeared fully oriented to person, place, time, and event. Pt had a blood pressure if 124/82, and pupils were 2 (L) and 3 (R) mm, and fully reactive to light. Pt states his pupils are irregular in size
BODY ACHES; HEADACHE; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 to Left Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2020, Laboratory data included: Body temperature (NR: not provided) 100.2 UNITS UNSPECIFIED. On 10-MAR-2021, the subject experienced body aches. On 10-MAR-2021, the subject experienced headache. On 10-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, body aches, and fever. This report was non-serious.
I experienced arm soreness and fatigue after injection. On 01/05/2022 when I went in for my yearly CT Scan of your lungs they found a mass in the lower left lobe of my lung, and all previous scans had shown clear with no symptoms attributed. I was diagnosed with lymphoma after a bronchoscopy 01/28/2022 after they performed a PET Scan which also highlighted another cluster of cells between my lungs as well. I began chemotherapy on 03/29/2022 and the cancer is showing to be shrinking on my latest PET Scans. I had never had lymphoma prior to receiving Moderna dose 3/or my CT Scan 01/05/2022. Lot number was not listed on vaccination card.
every joint in her was so painful, she couldn't sleep, rollover, or walk. She said she had a lot of pain in every joint of her body; neck, feet, ankles, and everything; every joint in her was so painful, she couldn't sleep, rollover, or walk. She said she had a lot of pain in every joint of her body; neck, feet, ankles, and everything; every joint in her was so painful, she couldn't sleep, rollover, or walk. She said she had a lot of pain in every joint of her body; neck, feet, ankles, and everything; get sick; injection site irritation; wheezy; This is a spontaneous report from a contactable other HCP. A 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot Number: EN6198) via an unspecified route of administration, administered in Arm Left on 01Mar2021 as SINGLE DOSE for covid-19 immunisation. Medical history included ongoing rheumatoid arthritis, diabetes mellitus, cardiac pacemaker insertion from Dec2020 and ongoing, ongoing asthma and covid-19 from Mar2020. The patient's concomitant medications were not reported. On 02Mar2021, the patient stated that every joint in her was so painful, she couldn't sleep, rollover, or walk. she said she had a lot of pain in every joint of her body; neck, feet, ankles, and everything. The patient also had wheezy on Mar2021, get sick on 02Mar2021 and injection site irritation on 01Mar2021. The events joint pain, insomnia and gait disturbances were assessed as disability by the reporter. Outcome of the events insomnia, joint pain and gait disturbances were recovering while outcome of the remaining events was recovered on an unspecified date.; Sender's Comments: The information currently provided is very limited hence the causal association between the suspect drug and reported events arthralgia, insomnia and gait disturbance cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Cold symptoms, ear infection. My arm turned red and swollen shoulder to elbow. It started 10 days later. I have a history of extensive immune work ups. I have know delayed reactions.   I have had 2 bee stings on opposite hands and they did not react until 10 days later. . That is normal for me to have delayed reactions. I also Mannose deficiency . I have had extensive  immune work up and then repeated at clinic.
PATIENT CAME IN 10/16/23 TO INFORM US PATIENT EXPERIENCE PARALYSIS ON LEFT SIDE OF FACE 2-3 DAYS AFTER RECEIVING COMIRNATY ON 10/6/2023.  PATIENT COMPLAINED OF REDUCED HEARING, NO PROBLEM WITH VISION, PROBLEM WITH CONTROLLING MOUTH MUSCLES. HE ALSO NOTED THAT NORMALLY HE FEELS PAIN IN LOWER EXTREMETIES (BOTH FEET AND BOTH HANDS) BUT NO LONGER HAVE PAIN. HE BELIEVES IT'S NEUROLOGICAL EFFECTS.  I ADVISED HIM TO IMMEDIATELY SEE A DOCTOR WHICH HE HAS NOT.
ACUTE RESPIRATORY FAILURE 3/29/2023 ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/29/2023 ACUTE RESPIRATORY FAILURE
24 hours, post vax, developed sinus congestion, sneezing and coughing, for 6 days and continued these symptoms. Developed soreness and induration at injection site.
Dizziness, Headache, Myalgia, Fever, inj site sore/red/swollen; chills, malaise, body aches Narrative: Day 1-5 - inj site soreness, swelling, redness; day 1-4 headache, dizziness, chills, malaise, low grade fever, bodyache
Extremely hot around injection site. Pain, swelling, redness. The swelling and redness expanded over the course of 7 days so that the entire upper arm was affected, then started to recede. Itchiness and soreness in the muscles and bones followed for the next 5 days. Currently, there is a patch about 4 inches long near the injection site where new, raised and itchy bumps have formed.
Altered mental status, fever, lethargy, ataxia, lumbar puncture and MRI consistent with acute demyelinating encephalomyelitis 12/10/2009 ED note for 11/30/2009, 12/22-23/2009 DC summary/MR for 11/30-12/9/2009,  patient with c/o's cough, congestion, nasal drainage, loss of appetite, had been seen at another facility on 11/29/2009, cat scan, cxr and labs wnl, was dx'd as viral syndrome and dc'd, now with c/o's weakness of bilateral LE's, abnormal gait, increased irritability, to PICU, O2 therapy, NG tube , LP done, IV ABX and antivirals, IV Solu-Medrol, ADEM with quadriparesis and mutism, referred for Acute Inpatient Rehab
immun given 31JUL93 temp w/APAP; persisted till 2AUG where mom notice lack of coordination, trouble walking down halls w/o touching bumping into tthem when feeding self using fork miss mouth; has motor problems; neurologic;
Boostrix underage administration; Boostrix instead of Dtap catch up administration; Underdose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number TR292, expiry date 03-NOV-2024) for prophylaxis.   On 23-JUN-2023, the patient received Boostrix. On 23-JUN-2023, an unknown time after receiving Boostrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Boostrix underage administration), wrong vaccine administered (Verbatim: Boostrix instead of Dtap catch up administration) and underdose (Verbatim: Underdose). The outcome of the inappropriate age at vaccine administration, wrong vaccine administered and underdose were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-JUN-2023. Medical assistant reported on 26 June 2023 that male patient 3 years and 5 month of age who happened to be her son. The vaccine was administer on 23 June 2023 Boostrix instead of Dtap catch up administration the reporter did not know where in the series the patient was.  The reporter did not consent to follow-up.  The vaccine administration facility was the same as Primary Reporter. A 3 years and 5 month patient received a dose of Boostrix instead of Dtap vaccine, which led to wrong vaccine administered, inappropriate age at vaccine administration and underdose.
This spontaneous report was received from a pharmacist and refers to a 27-year-old male patient. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history. On 07-NOV-2017, the patient was vaccinated with the third dose of GARDASIL 9, (dose, route, anatomical location, lot number and expiration date were not reported) for prophylaxis. No adverse effects were reported.
Stomach ache; fatigue; This is a spontaneous report from a contactable pharmacist. A 13-years-old female patient received BNT162B2 (BNT162B2, Solution for injection, Lot number was not reported) via an unspecified route of administration in an unknown date in 2021 as 2nd dose, single dose for covid-19 immunization. Medical history was none. The patient previously took first dose of BNT162B2 (BNT162B2, Solution for injection) for covid-19 immunization and no reaction on exposure to vaccine. The concomitant medications were not reported. The patient experienced stomach ache, fatigue in an unknown date in 2021. Reported that, event took place after use of product. Outcome of the events were recovered on an unknown date in 2021.  Reporter does not wish to be contacted for follow-up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Acute ischemic vertibrobasilar artery thalmic stroke involving left-sided vessel Symptoms: numbness in right side of mouth; slurred speech, loss of coordination on right side Treatment: physical & occupational therapy Outcome: TBD - favorable prognosis
My symptoms began with runny nose, congestion in my nose and chest, then a cough.  I've had some headaches, chills and diarrhea.  This began taking Paxlovid on Monday, March 13th.  My symptoms today are better but the congestion is still here just not as severe.
Patient stated he felt hot and dizzy. Gave patient cool compresses to hold on his head and an ice pack. Patient has clammy skin, was pale and cold to the touch with vomiting. Patient waited in office for 30 minutes before he was able to go home.
Received TWINRIX #2 TD and H1N1 vaccine-developed a flat rash to inner elbows x 1 day denies any issues.
injection site became very red; itchy kind of like a bug bite; injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site became very red), VACCINATION SITE PRURITUS (itchy kind of like a bug bite) and VACCINATION SITE SWELLING (injection site swollen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site became very red), VACCINATION SITE PRURITUS (itchy kind of like a bug bite) and VACCINATION SITE SWELLING (injection site swollen). On 29-Jan-2021, VACCINATION SITE PRURITUS (itchy kind of like a bug bite) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (injection site became very red) outcome was unknown and VACCINATION SITE SWELLING (injection site swollen) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.    Most recent FOLLOW-UP information incorporated above includes: On 29-Jan-2021: Event information updated.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Patient's medical history was unknown. On 16-JUL-2013 the patient was vaccinated with first dose of ZOSTAVAX vial (strength, dose unit, lot number and expiry date, route unknown). No concomitant medication were reported. Patient received two doses of ZOSTAVAX. On 13-JUN-2014 the patient was vaccinated with second dose of ZOSTAVAX (strength, dose unit, lot number and expiry date, route unknown) and no adverse effect was reported. The outcome of patient had received two doses of ZOSTAVAX and no adverse effect was unknown. No further information was provided. Additional information has been requested.
Patient presented to the ED and was subsequently hospitalized with a pulmonary embolism within 6 weeks of receiving COVID vaccination. Patient also hospitalized on 3/12/21.
Headache; Fatigue; Nausea; When it was injected quite a bit ran down my arm; A spontaneous report was received from a 70-year-old female nurse who received Moderna's COVID-19 Vaccine (mRNA-1273) and when it was injected quite a bit ran down the arm and the patient experienced headache, fatigue and nausea.   The patient's medical history was not provided. The patient current condition included autoimmune disorder. No relevant concomitant medications were reported.    On 11 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot 025J20-2A) intramuscularly in the arm for prophylaxis of COVID-19 infection.   During the administration of the vaccine, the patient experienced when it was injected, quite a bit ran down the arm. On 12 Jan 2021, the patient woke up with a headache, fatigue and had nausea. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event, when it was injected quite a bit ran down the arm, was considered resolved on 11 Jan 2021. The outcome of the events, headache, fatigue and nausea, were considered resolved on 12 Jan 2021.; Reporter's Comments: This spontaneous report refers to a case of q 70-year-old female  patient who experienced non-serious events of when it was injected quite a bit ran down the arm (Incomplete dose administered) and the patient experienced headache, fatigue and nausea to hours after administration of  mRNA-1273 (lot # 025J20-2A), Exp date-unknown). The events of headache, fatigue and nausea are temporally associated with vaccine administration and consistent with the known safety profile of the vaccine, hence a causal association cannot be excluded.  The event of when it was injected quite a bit ran down the arm is considered not applicable.
TIGHTNESS IN CHEST, CHILLS, MILD FEVER, REALLY FATIGUED.
Upper lip numbness and tingling that started within first 30 minutes after injection, and difficulty initiating a swallow with sensation of mild swelling in posterior oropharynx with onset approximately 45 minutes after injection.
Expired vaccine administered beyond 12 hours expiration for punctured vial; Vial was first punctured on 05-Sep-2021 at 11:00 AM and was kept in refrigerator/ was discarded on 06-Sep-2021 after 04:30 PM; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours expiration for punctured vial) and PRODUCT STORAGE ERROR (Vial was first punctured on 05-Sep-2021 at 11:00 AM and was kept in refrigerator/ was discarded on 06-Sep-2021 after 04:30 PM) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Sep-2021 at 4:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Sep-2021 at 11:00 AM, the patient experienced PRODUCT STORAGE ERROR (Vial was first punctured on 05-Sep-2021 at 11:00 AM and was kept in refrigerator/ was discarded on 06-Sep-2021 after 04:30 PM). On 06-Sep-2021 at 4:30 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours expiration for punctured vial). On 06-Sep-2021, PRODUCT STORAGE ERROR (Vial was first punctured on 05-Sep-2021 at 11:00 AM and was kept in refrigerator/ was discarded on 06-Sep-2021 after 04:30 PM) had resolved. On 06-Sep-2021 at 4:30 PM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered beyond 12 hours expiration for punctured vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No Treatment information was provided.  The vial was initially stored in the refrigerator on 31-Aug-2021. The vaccine was administered at room temperature. The vial did not undergo any previous temperature excursions. The reporter stated that the total amount of time the vial was exposed to room temperature range 46° to 77° F was from 06-Sep-2021 9:00 AM.   This case was linked to MOD-2021-311383 (Patient Link).